Suppr超能文献

II型家族性醛固酮增多症:一个大家族的描述及醛固酮合成酶(CYP11B2)基因排除研究

Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.

作者信息

Torpy D J, Gordon R D, Lin J P, Huggard P R, Taymans S E, Stowasser M, Chrousos G P, Stratakis C A

机构信息

Unit on Genetics and Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Clin Endocrinol Metab. 1998 Sep;83(9):3214-8. doi: 10.1210/jcem.83.9.5086.

Abstract

Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and hypersecretion of aldosterone due to adrenocortical hyperplasia or an aldosterone-producing adenoma; unlike FH type I (FH-I), hyperaldosteronism in FH-II is not suppressible by dexamethasone. Of a total of 17 FH-II families with 44 affected members, we studied a large kindred with 7 affected members that was informative for linkage analysis. Family members were screened with the aldosterone/PRA ratio test; patients with aldosterone/PRA ratio greater than 25 underwent fludrocortisone/salt suppression testing for confirmation of autonomous aldosterone secretion. Postural testing, adrenal gland imaging, and adrenal venous sampling were also performed. Individuals affected by FH-II demonstrated lack of suppression of plasma A levels after 4 days of dexamethasone treatment (0.5 mg every 6 h). All patients had negative genetic testing for the defect associated with FH-I, the CYP11B1/CYP11B2 hybrid gene. Genetic linkage was then examined between FH-II and aldosterone synthase (the CYP11B2 gene) on chromosome 8q. A polyadenylase repeat within the 5'-region of the CYP11B2 gene and 9 other markers covering an approximately 80-centimorgan area on chromosome 8q21-8qtel were genotyped and analyzed for linkage. Two-point logarithm of odds scores were negative and ranged from -12.6 for the CYP11B2 polymorphic marker to -0.98 for the D8S527 marker at a recombination distance (theta) of 0. Multipoint logarithm of odds score analysis confirmed the exclusion of the chromosome 8q21-8qtel area as a region harboring the candidate gene for FH-II in this family. We conclude that FH-II shares autosomal dominant inheritance and hyperaldosteronism with FH-I, but, as demonstrated by the large kindred investigated in this report, it is clinically and genetically distinct. Linkage analysis demonstrated that the CYP11B2 gene is not responsible for FH-II in this family; furthermore, chromosome 8q21-8qtel most likely does not harbor the genetic defect in this kindred.

摘要

II型家族性醛固酮增多症(FH-II)的特征为常染色体显性遗传,以及由于肾上腺皮质增生或醛固酮分泌性腺瘤导致的醛固酮分泌过多;与I型家族性醛固酮增多症(FH-I)不同,FH-II中的醛固酮增多症不能被地塞米松抑制。在总共17个有44名患病成员的FH-II家族中,我们研究了一个有7名患病成员的大家系,该家系对连锁分析具有参考价值。通过醛固酮/肾素活性比值试验对家族成员进行筛查;醛固酮/肾素活性比值大于25的患者接受氟氢可的松/盐抑制试验,以确认醛固酮自主分泌。还进行了体位试验、肾上腺成像和肾上腺静脉采血。受FH-II影响的个体在地塞米松治疗4天(每6小时0.5毫克)后,血浆醛固酮水平未受抑制。所有患者针对与FH-I相关的缺陷(CYP11B1/CYP11B2杂交基因)的基因检测均为阴性。然后检查了FH-II与8号染色体q臂上的醛固酮合酶(CYP11B2基因)之间的遗传连锁。对CYP11B2基因5'-区域内的一个多聚腺苷酸重复序列以及覆盖8号染色体q21-8qtel上约80厘摩区域的其他9个标记进行基因分型,并分析连锁情况。在重组距离(θ)为0时,两点对数优势分数为阴性,范围从CYP11B2多态性标记的-12.6到D8S527标记的-0.98。多点对数优势分数分析证实,在这个家族中,8号染色体q21-8qtel区域被排除为携带FH-II候选基因的区域。我们得出结论,FH-II与FH-I一样具有常染色体显性遗传和醛固酮增多症,但正如本报告中所研究的大家系所示,它在临床和遗传方面是不同的。连锁分析表明,CYP11B2基因在这个家族中与FH-II无关;此外,8号染色体q21-8qtel很可能不携带这个家系中的遗传缺陷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验